Pepper Bio

Trans-omics platform for drug target ID

Human 3 criteria:
No items found.

Pepper Bio is developing the word’s first drug target ID platform that incorporates phosphoproteomics. Phosphoproteomics is an emerging field that allows researchers to view the changes (phosphorylation) of proteins over time, enabling a more causal understanding of disease biology.

Under the radar for now - more info soon.

2023

XEIA invests

The latest from 

Pepper Bio

coming soon . . .

Want more from XEIA?

Stay up to date on Human 3 - the new epoch of health, wellbeing and performance

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.
Thank you! You've been added to our mailing list.
Oops! Something went wrong while submitting the form.
X-disciplinary Exploration, Investment & Acceleration

© 2025 XEIA Venture Partners, LLC